Novimmune Competitors and Similar CompaniesClear all

Novimmune's competitors and similar companies include Valneva, EMS Pharma, Alembic Pharmaceuticals and UCB.

	Novimmune Novimmune is a company that focuses on its bispecific technology to build a pipeline of multispecific antibodies under the brand Light Chain Bioscience.	Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 1998	Founding Date 2013	Founding Date 1964	Founding Date 2010	Founding Date 1928
Type	Type Private	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Plan-les-Ouates, CH HQ	Locations Saint-Herblain, FR HQ Wien, AT Kirkland, CA Lyon, FR Solna, SE Fleet, GB Livingston, GB see more	Locations BR HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 80	Employees 713	Employees 12,7441% increase	Employees 14,858	Employees 9,052
Valuation ($)	Valuation ($) N/A	Valuation ($) 482.5 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €157.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods €8.2m (FY, 2025)	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit €177.7m (FY, 2025)	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit €7.2b (FY, 2025)
Net income	Net income N/A	Net income (€115.2m) (FY, 2025)	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income €1.6b (FY, 2025)
Funding
Total funding raised	Total funding raised $ 239.1m	Total funding raised $ 51.7m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A